Biovail Corporation (NYSE: BVF) today commented on a proposed clinical trial recently announced by Teva Pharmaceutical Industries Ltd (Nasdaq: TEVA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE